1. "Breast Medicine Service"
  2. "Howard Scher"
  3. "American Association for Cancer Research"
  4. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (8)
Groups
  1. Breast Medicine Service (21)
  2. Department of Medicine (21)
  3. GSK Faculty (21)
  4. Genitourinary Oncology Service (21)
  5. Human Oncology and Pathogenesis Program (21)
  6. Solid Tumor Oncology Division (21)

More Groups

People
  1. Howard Scher (21)
  2. David Solit (17)
  3. Neal Rosen (15)
  4. Pamela Munster (5)
  5. Andrea Basso (4)
  6. Larry Norton (4)

More People

Years
  1. 2022 (2)
  2. 2020 (1)
  3. 2019 (2)
  4. 2018 (1)
  5. 2014 (1)
  6. 2009 (1)

More Years

Publications
  1. Cancer Research (8)
  2. Clinical Cancer Research (8)
  3. Proceedings of the American Association for Cancer Research Annual Meeting (4)
  4. Molecular Cancer Therapeutics (1)
Publishers
  1. American Association for Cancer Research (21)

Results (21)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer
    Journal Article

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Nguyen, B.; Stopsack, K. H.; Kreitzer, C.; Rajanala, S. H.; Ghale, R.; Mazzu, Y. Z.; Pillarsetty, N. V. K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Optimal strategy and benefit of pulsed therapy depend on tumor heterogeneity and aggressiveness at time of treatment initiation
    Journal Article

    Mathur, D.; Taylor, B. P.; Chatila, W. K.; Scher, H. I.; Schultz, N.; Razavi, P.; Xavier, J. B.
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; Coombs, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • BRCA-mediated tumorigenesis is origin and cell-type dependent
    Meeting Abstract

    Jonsson, P.; Cheng, M. L.; Bandlamudi, C.; Srinivasan, P.; Chavan, S. S.; Friedman, N. D.; Rosen, E. Y.; Richards, A. L.; Bouvier, N.; Selcuklu, S. D.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Gao, T.; Devlin, S. M.; Kelly, D.; Coombs, C.; Patel, M.; Moarii, M.; Bernard, E.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Estimation of tumor-derived mutant allele fractions in cfDNA by shallow whole genome sequencing and fragment size analysis
    Meeting Abstract

    Yang, J.; Marass, F.; Ulz, P.; Shady, M.; Cheng, M. L.; Kothari, P.; Gedvilaite, E.; Somnay, S.; Shukla, N.; Modak, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • The antitumor effects of PI3K beta inhibitors in PTEN negative prostate cancer are enhanced by inhibition of reactivated PI3K alpha signaling
    Meeting Abstract

    Schwartz, S.; Carver, B. S.; Wongvipat, J.; Rodrik-Outmezguine, V. ; Destanchina, E.; Trigwell, C.; Barry, S.; Baselga, J.; Chandarlapaty, S.; Scher, H. I.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer
    Journal Article

    Welsbie, D. S.; Xu, J.; Chen, Y.; Borsu, L.; Scher, H. I.; Rosen, N.; Sawyers, C. L.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer
    Journal Article

    Solit, D. B.; Ivy, S. P.; Kopil, C.; Sikorski, R.; Morris, M. J.; Slovin, S. F.; Kelly, W. K.; Delacruz, A.; Curley, T.; Heller, G.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Pulsatile administration of the epidermal growth factor receptor inhibitor gefitinib is significantly more effective than continuous dosing for sensitizing tumors to paclitaxel
    Journal Article

    Solit, D. B.; She, Y.; Lobo, J.; Kris, M. G.; Scher, H. I.; Rosen, N.; Sirotnak, F. M.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save